Pharmaceutical Investing Acerus Announces Expansion of NATESTO® Agreement with medac and the Submission of NATESTO® Dossier in Europe
Pharmaceutical Investing Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
Pharmaceutical Investing Supernus Announces First Quarter 2018 Financial Results and Record Quarterly Revenue
Pharmaceutical Investing Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for Development of OPNT003
Pharmaceutical Investing EyeGate Receives FDA Feedback on Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
Pharmaceutical Investing Pernix Therapeutics Announces Return to Market of Zohydro ER with BeadTek 20 mg
Pharmaceutical Investing Sonoma Pharmaceuticals Introduces New and Improved Acuicyn™ Antimicrobial Eyelid and Eyelash Hygiene Solution
Skyharbour Partner Company Terra Clean Energy Completes Winter Drill Program with Encouraging Results and Prepares a Significant Summer Drill Program at the South Falcon East Uranium Project
Riverside Resources Moves Ahead on Plan to Spin Out Blue Jay to Shareholders After Approval at the Annual and Special Meeting
1911 Gold Intersects up to 14.97 g/t Gold over 2.70 m including 71.60 g/t Au over 0.50 m on SAM Southeast Zone at True North
